ethosuximide has been researched along with Anochlesia in 2 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jadhav, JH | 1 |
| Balsara, JJ | 1 |
| Chandorkar, AG | 1 |
| Zetler, G | 1 |
2 other studies available for ethosuximide and Anochlesia
| Article | Year |
|---|---|
Preliminary observations regarding the cataleptogenic activity of ethosuximide in the mouse.
Topics: Animals; Apomorphine; Atropine; Catalepsy; Dose-Response Relationship, Drug; Ethosuximide; Humans; M | 1980 |
Drug-induced catalepsy as influenced by convulsant and anticonvulsant drugs.
Topics: Animals; Anticonvulsants; Arecoline; Bemegride; Caffeine; Catalepsy; Central Nervous System Stimulan | 1973 |